OBIO Companies Advance in 2017 Interface Health Challenge X

Six OBIO companies have made it to the Top 60 qualifying round for this year's Interface Health Challenge X competition:  

  • Komodo OpenLab (CAAP 2015)
  • KE2 Technologies (CAAP 2016)
  • iamsick.ca (Pre-CAAP)
  • MyndPlan (Pre-CAAP)
  • Steadiwear (Pre-CAAP)
  • Hypercare (Pre-CAAP)

This round of the annual IHCX competition involves a public voting process to select the Top 50 entrants.

To vote, click here.

2017-IHCX-banner
Previous
Previous

US FDA launches Digital Health Innovation Action Plan & Pre-Certification Software Pilot Program

Next
Next

BIO Investor Forum Now Accepting Applications to Present